Teva Launches First-to-market Authorized Generic Version Of Epiduo Forte Gel In The U.S.

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced the launch of an authorized generic of Epiduo Forte Gel, or adapalene and benzoyl peroxide gel 0.3%/2.5%, in the U.S. It is a topical prescription medicine used to treat acne vulgaris.

The company noted that Epiduo Forte Gel had annual sales of $253 million in the U.S., according to IQVIA data, as of September 2021.

Christine Baeder, Chief Operating Officer US Generics, Teva USA, said: "Continuing to advance and launch much-needed generic drugs is critical to ensuring access to quality medicines to everyone who needs them."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Omni-channel fashion retailer Macy's, Inc. (M) reported Thursday a first-quarter net income of $286 million or $0.98 per share, sharply higher than $103 million or $0.32 per share in the prior-year quarter. Excluding items, adjusted net income for the quarter was $315 million or $1.08 per share, compared... Richmond, Utah-based Casper's Ice Cream is recalling its 56 ounce tubs of "Red Button Vintage Creamery Canadian Vanilla Ice Cream" due to undeclared allergen, the U.S. Food and Drug Administration said. According to the agency, a limited number of the product were mispackaged with Burnt Almond Fudge Ice Cream containing undeclared almonds. Teva Pharmaceuticals USA, Inc. has recalled one lot of platelet-reducing drug Anagrelide in the form of capsules due to dissolution test failure detected during routine stability testing, the U.S. Food and Drug Administration, or FDA, said in a statement.
Follow RTT